John Kenneth Jenkins Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

John Kenneth Jenkins is of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 2,816 shares of CRBP, which is worth approximately $35,904. The most recent transaction as insider was on May 30, 2024, when has been sold 2,783 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.82K

0% 3M change

n/a 12M change

Total Value Held $35,904

John Kenneth Jenkins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 30 2024	BUY Grant, award, or other acquisition	-	2,783 Added 49.71%	2,816 Common Stock, par valu...

Also insider at

PRVB

Provention Bio, Inc. Healthcare

Director

JKJ